Advanced Search
ZHAO Chong, WANG Qiang, WU Fenping, LIU Shenglan. Relationship of LncRNA AC010145.4 Expression with Prognosis and Chemoresistance of Small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2017, 44(10): 677-681. DOI: 10.3971/j.issn.1000-8578.2017.17.0504
Citation: ZHAO Chong, WANG Qiang, WU Fenping, LIU Shenglan. Relationship of LncRNA AC010145.4 Expression with Prognosis and Chemoresistance of Small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2017, 44(10): 677-681. DOI: 10.3971/j.issn.1000-8578.2017.17.0504

Relationship of LncRNA AC010145.4 Expression with Prognosis and Chemoresistance of Small Cell Lung Cancer

More Information
  • Corresponding author:

    LIU Shenglan, E-mail: lanlan16358221@qq.com

  • Received Date: May 07, 2017
  • Revised Date: July 13, 2017
  • Available Online: January 12, 2024
  • Objective 

    To investigate the expression of long non-coding RNA AC010145.4 (LncRNA AC010145.4) and its relationship with prognosis and chemoresistance of small cell lung cancer (SCLC) patients.

    Methods 

    The expression of LncRNA AC010145.4 in 67 cases of SCLC tissues, 27 cases of para-cancerous tissues and 40 cases of normal lung tissues were detected by real-time fluorescent quantitative PCR. The relationship of LncRNA AC010145.4 expression with clinicopathological characteristics was analysed by χ2 test. The relationship between AC010145.4 expression and survival time of SCLC patients were analyzed by Kaplan-Meier analysis. Univariate and multivariate analysis were used to analyze prognosis factor of SCLC.

    Results 

    The expression level of LncRNA AC010145.4 in SCLC tissues was higher than those in para-cancerous tissues and normal lung tissues (all P < 0.001). The expression of LncRNA AC010145.4 was significantly higher in chemoresistance patients than that in chemosensitive patients (P < 0.05). LncRNA AC010145.4 expression was positively correlated with disease stage, lymph node metastasis, distant metastasis, chemosensitivity (all P < 0.05). The overall survival time and progression-free survival time of the patients with high LncRNA AC010145.4 expression were shorter than those with low LncRNA AC010145.4 expression (all P < 0.001). LncRNA AC010145.4 expression, disease stage and distant metastasis were independent prognostic factors (all P < 0.05).

    Conclusion 

    LncRNA AC010145.4 is involved in the occurrence and development of SCLC, and may be used as a molecular marker for the prognosis evaluation of SCLC patients.

  • [1]
    Butler KM, Rayens MK, Wiggins AT, et al. Association of smoking in the home with lung cancer worry, perceived risk, and synergistic risk[J]. Oncol Nurs Forum, 2017, 44(2):E55-63.
    [2]
    Caswell G, Seymour J, Crosby V, et al. Lung cancer diagnosed following an emergency admission:exploring patient and carer perspectives on delay in seeking help[J]. Support Care Cancer, 2017, 25(7):2259-66. doi: 10.1007/s00520-017-3633-8
    [3]
    Huang J, Peng J, Guo L. Non-coding RNA:a new tool for the diagnosis, prognosis, and therapy of small cell lung cancer[J]. J Thorac Oncol, 2015, 10(1):28-37. doi: 10.1097/JTO.0000000000000394
    [4]
    Park S, Lee E, Rhee S, et al. Correlation between semi-quantitative (18) F-FDG PET/CT parameters and Ki-67 expression in small cell lung cancer[J]. Nucl Med Mol Imaging, 2016, 50(1):24-30. doi: 10.1007/s13139-015-0363-z
    [5]
    Xiao F, Bai Y, Chen Z, et al. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100[J]. Eur J Cancer, 2014, 50(8):1541-54. doi: 10.1016/j.ejca.2014.01.024
    [6]
    Haixia P, Yifeng B, and Honglin H. Role and clinical significance of RLIP76 in regulation of multi-drug resistance of small cell lung cancer[J]. Zhonghua Zhong Liu Za Zhi, 2015, 37(4):266-71. http://www.ncbi.nlm.nih.gov/pubmed/26462890
    [7]
    Luo S, Bai Y, Lan H. Influence of interference of WIG-1 on the multi-drug resistance in small cell lung cancer[J]. Zhonghua Zhong Liu Za Zhi, 2014, 36(10):733-8. http://www.ncbi.nlm.nih.gov/pubmed/25567302
    [8]
    Williamson L, Saponaro M, Boeing S, et al. UV Irradiation Induces a Non-coding RNA that Functionally Opposes the Protein Encoded by the Same Gene[J]. Cell, 2017, 168(5):843-55. doi: 10.1016/j.cell.2017.01.019
    [9]
    Zhuo C, Hou W, Hu L, et al. Genomic editing of non-coding rna genes with crispr/cas9 ushers in a potential novel approach to study and treat schizophrenia[J]. Front Mol Neurosci, 2017, 10:28. doi: 10.3389/fnmol.2017.00028/full
    [10]
    Jin Y, Cui Z, Li X, et al. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer[J]. Oncotarget, 2017, 8(16):26090-9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432240/
    [11]
    Li H, Jiang X, Niu X. Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53[J]. Med Sci Monit, 2017, 23:919-28. doi: 10.12659/MSM.903462
    [12]
    Qi X, Shao M, Sun H, et al. Long non-coding RNA SNHG14 promotes microglia activation by regulating miR-145-5p/PLA2G4A in cerebral infarction[J]. Neuroscience, 2017, 348:98-106. doi: 10.1016/j.neuroscience.2017.02.002
    [13]
    Huang NS, Chi YY, Xue JY, et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1(MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer[J]. Oncotarget, 2016, 7(25):37957-65. doi: 10.18632/oncotarget.v7i25
    [14]
    Zhou C, Ye L, Jiang C, et al. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1alpha activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer[J]. Tumour Biol, 2015, 36(12):9179-88. doi: 10.1007/s13277-015-3453-8
    [15]
    Qiu M, Xu Y, Yang X, et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer[J]. Tumour Biol, 2014, 35(6):5375-80. doi: 10.1007/s13277-014-1700-z
    [16]
    Shi X, Sun M, Liu H, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer[J]. Mol Carcinog, 2015, 54(Suppl 1):E1-12. http://www.ncbi.nlm.nih.gov/pubmed/24357161
    [17]
    Niu Y, Ma F, Huang W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2[J]. Mol Cancer, 2017, 16(1):5. doi: 10.1186/s12943-016-0575-6
    [18]
    Huang C, Liu S, Wang H, et al. LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer[J]. Am J Transl Res, 2016, 8(11):5025-34. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126345/
  • Related Articles

    [1]LU Hui, XIE Zhengyuan. Research Progress in Noninvasive Early Diagnosis of Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2023, 50(1): 75-80. DOI: 10.3971/j.issn.1000-8578.2023.22.0642
    [2]YAN Xiaolu, GAO Zhe, LI Qingxia. Clinical Significance of Serum Levels of IGF-1 and CA153 in Patients with Recurrence of Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 481-482. DOI: 10.3971/j.issn.1000-8578.2015.05.013
    [3]Fu Weijin, Mi Hua, Liu Deyun, Yan Haibiao, Huang Weihua, Mo Zengnan. Diagnosis and Treatment of Adrenal Schwannoma[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 87-89. DOI: 10.3971/j.issn.1000-8578.2013.01.022
    [4]CHENG-Bo, ZHANG Ai-min, MA Fu-jun, LI Shu-guang, HU Hai-long, LIU Li-wei, HAN Ru-fa. Diagnosis and Treatment of Renal Pelvis Carcinoma (Report of 92 Cases)[J]. Cancer Research on Prevention and Treatment, 2011, 38(08): 933-936. DOI: 10.3971/j.issn.1000-8578.2011.08.020
    [5]QU Hong-yan, PANG DA, XUE Ying-wei, et al, . Diagnosis and treatment of spleen tumor[J]. Cancer Research on Prevention and Treatment, 2002, 29(04): 316-316. DOI: 10.3971/j.issn.1000-8578.3303
    [6]HUANG ZHao-sui, WANG Yi-ming, HUANG CHun-hong, et al, . The application of TSGF test in the diagnosis of carcinosis[J]. Cancer Research on Prevention and Treatment, 2002, 29(03): 215-216. DOI: 10.3971/j.issn.1000-8578.1552
    [7]CAI Xiao-qing, LI Wen-guang. The diagnosis and treatment of the bladder mixed tumor[J]. Cancer Research on Prevention and Treatment, 2002, 29(02): 133-134. DOI: 10.3971/j.issn.1000-8578.941
    [8]CT in Diagnosis of Maxillary Sinus Neoplasm[J]. Cancer Research on Prevention and Treatment, 1999, 26(6): 455-456.
    [9]Lu Guangsheng, Dou Kefeng, Li Kaizhong, . Diagnosis and Surgical Treatment Extrahepatic of Cholangiocarcinoma[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 127-128.
    [10]Wang Zi-Bin, . Clinical Radiological Diagnosis of Pulmonary Carcinoma in Special Types[J]. Cancer Research on Prevention and Treatment, 1995, 22(4): 241-244.
  • Cited by

    Periodical cited type(13)

    1. 吴杨,隋雨桐,李斌鹏,韩路拓,姜家康. 激酶/转录因子信号通路调控肺癌机制及中医药干预的研究进展. 世界中医药. 2025(01): 142-147+154 .
    2. 曹家瑞,冯博,马纯政,陈伟霞,喻江凡,曹莎莎,张振予,欧阳文慧. 中医药调控JAK/STAT信号通路干预肺癌的机制研究进展. 中国实验方剂学杂志. 2025(09): 265-276 .
    3. 梁帅,尹怡,刘湘花,汪保英,骆文龙,龙云凯,任振杰,王祥麒. 升降理肺消瘤汤对Lewis肺癌小鼠免疫炎性反应和JAK2/STAT3信号通路的影响. 辽宁中医药大学学报. 2024(04): 27-32 .
    4. 张彩蝶,靳艳,张德德. 润肺益肾饮对肺癌荷瘤大鼠的抑瘤作用和肿瘤免疫微环境的影响. 天津医药. 2024(04): 362-366 .
    5. 孙喜,王召路,贾谨睿,王梦洋,孙润卓,王鹏,史新娥. 虫草素及其在生猪养殖中的应用. 畜牧兽医杂志. 2024(04): 1-7 .
    6. 兰春燕,杨小兰,贺雪峰,赵丹,杨海燕. 甘草苷对胃癌荷瘤小鼠免疫功能的调节作用及机制研究. 中国药房. 2024(15): 1862-1867 .
    7. 张景淇,郭静,陈娅欣,蒲玥衡,向俊杰. 中药调控肺癌相关信号通路研究进展. 中国实验方剂学杂志. 2024(19): 233-244 .
    8. 张孟恩,韩睿,徐超,庞训胜,王世琴. 地顶孢霉培养物在反刍动物生产中的应用研究进展. 中国畜牧杂志. 2024(12): 70-74 .
    9. 高铭,丁美灵,雷紫琴,胡靖文,栾飞,曾南. 荆防败毒散及其中成药制剂研究进展. 中药药理与临床. 2023(05): 112-118 .
    10. 朱亚兰,吕世文,曾晨欣,徐媛青. 苍术素对非小细胞肺癌细胞上皮间质转化的影响及机制研究. 浙江医学. 2023(10): 1013-1018 .
    11. 陈才伟,陈家亮,李华娟,方芳,文方玲. 虫草素调节MAPK/AP-1信号通路对慢性阻塞性肺疾病大鼠肺组织损伤的影响. 临床肺科杂志. 2023(11): 1656-1661 .
    12. 李翔子,王西双,范建伟,杨田野,王丽娟,孙颖,姚景春. 荆防合剂通过抑制JAK2-STAT3信号通路调节荨麻疹小鼠脾脏T淋巴细胞亚群的平衡. 中国中药杂志. 2022(20): 5473-5480 .
    13. 沈栩岚,黄凌霞. 虫草素的抗癌机理. 蚕桑通报. 2022(02): 33-34 .

    Other cited types(4)

Catalog

    Article views PDF downloads Cited by(17)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return